Imed Infinity Medical-Limited Partnership (TLV:IMED)

TLV:IMED Statistics

Total Valuation

TLV:IMED has a market cap or net worth of ILS 5.23 million. The enterprise value is -7.96 million.

Market Cap	5.23M
Enterprise Value	-7.96M

Important Dates

The next estimated earnings date is Wednesday, November 26, 2025.

Earnings Date	Nov 26, 2025
Ex-Dividend Date	n/a

Share Statistics

TLV:IMED has 4.04 million shares outstanding. The number of shares has decreased by -2.23% in one year.

Current Share Class	4.04M
Shares Outstanding	4.04M
Shares Change (YoY)	-2.23%
Shares Change (QoQ)	-4.12%
Owned by Insiders (%)	80.51%
Owned by Institutions (%)	20.34%
Float	n/a

Valuation Ratios

The trailing PE ratio is 5.67.

PE Ratio	5.67
Forward PE	n/a
PS Ratio	1.90
PB Ratio	0.18
P/TBV Ratio	0.18
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.72
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 23.81

Current Ratio	23.81
Quick Ratio	23.81
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 3.37% and return on invested capital (ROIC) is 1.00%.

Return on Equity (ROE)	3.37%
Return on Assets (ROA)	0.98%
Return on Invested Capital (ROIC)	1.00%
Return on Capital Employed (ROCE)	1.53%
Revenue Per Employee	39,373
Profits Per Employee	13,044
Employee Count	70
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +17.59% in the last 52 weeks. The beta is 0.33, so TLV:IMED's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	+17.59%
50-Day Moving Average	145.52
200-Day Moving Average	119.67
Relative Strength Index (RSI)	33.97
Average Volume (20 Days)	1,461

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TLV:IMED had revenue of ILS 2.76 million and earned 913,080 in profits. Earnings per share was 0.23.

Revenue	2.76M
Gross Profit	2.76M
Operating Income	434,640
Pretax Income	913,080
Net Income	913,080
EBITDA	n/a
EBIT	434,640
Earnings Per Share (EPS)	0.23

Balance Sheet

The company has 13.19 million in cash and n/a in debt, giving a net cash position of 13.19 million or 3.27 per share.

Cash & Cash Equivalents	13.19M
Total Debt	n/a
Net Cash	13.19M
Net Cash Per Share	3.27
Equity (Book Value)	28.43M
Book Value Per Share	7.27
Working Capital	12.68M

Cash Flow

Operating Cash Flow	-1.67M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of 15.77% and 33.13%.

Gross Margin	100.00%
Operating Margin	15.77%
Pretax Margin	33.13%
Profit Margin	33.13%
EBITDA Margin	n/a
EBIT Margin	15.77%
FCF Margin	n/a

Dividends & Yields

TLV:IMED does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.23%
Shareholder Yield	2.23%
Earnings Yield	17.45%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TLV:IMED has an Altman Z-Score of 4.47 and a Piotroski F-Score of 4.

Altman Z-Score	4.47
Piotroski F-Score	4